By Memorandum Opinion entered by The Honorable Leonard P. Stark in Citrix Systems, Inc. v. Workspot, Inc., Civil Action No. 18-588-LPS (D.Del. August 16, 2019), the Court denied the motion for preliminary injunction sought by plaintiff, Citrix Systems, Inc. In its complaint, Citrix asserted claims of infringement of U.S. Patent Nos. 7,949,677 (“the ‘677

By Memorandum Opinion entered by The Honorable Maryellen Noreika in Abbott Cardiovascular Systems, Inc. et al. v. Edwards Lifesciences Corp. et al., Civil Action No. 19-149-MN (D.Del. June 6, 2019), the Court denied the motion for preliminary injunction of Plaintiffs, Abbott Cardiovascular Systems, Inc. and Evalve, Inc., seeking to enjoin Defendants, Edwards Lifesciences Corp.

By Memorandum Opinion and Order entered by The Honorable Sue L. Robinson in AstraZeneca AB, et al. v. Camber Pharmaceuticals, Inc., Civil Action No. 15-927-SLR (D.Del., November 19, 2015), the Court granted the AstraZeneca plaintiffs’ motion for a preliminary injunction against defendant Camber Pharmaceuticals thereby enjoining defendant from selling its generic esomeprazole product (a

By Memorandum Opinion entered by The Honorable Sue L. Robinson in AstraZeneca AB, et al. v. Dr. Reddy’s Laboratories, Inc., Civil Action No. 15-988-SLR (D.Del., November 6, 2015), the Court granted the AstraZeneca plaintiffs’ motion for a temporary restraining order, including ordering defendant to immediately stop the sale, delivery, transfer, or other disposition of

By Memorandum Order entered by The Honorable Sue L. Robinson in In Re: Cyclobenzaprine Hydrochloride Extended-Release Capsule Patent Litigation, Civil Action No. 09-MD-2118-SLR (D.Del., May 20, 2011), the Court granted plaintiffs Eurand, Inc. and Anesta AG’s motion for temporary restraining order and enjoined defendants Mylan Pharmaceuticals, Inc. and Mylan, Inc. (collectively, “Mylan”) from manufacturing,